Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

News feed

Gazprom lowered its EBITDA forecast in 2025

18:06 GAZP

Gazprom's Board of Directors approves the budget for 2026

17:56 GAZP

Yandex will issue up to 4.1 million shares for the motivation program

17:06 YDEX

Kamaz updated its development strategy until 2030

16:19 KMAZ

Alrosa produced 29.7 million carats of diamonds in 2025

15:53 ALRS

Shareholders of IMCB approved dividends

12:39 GEMA

B2B-RTS discloses consolidated revenue and profit for the first time

12:11 SVCB

Yandex buys DIKIDI

11:23 YDEX

T-Technologies reported for 11 months of 2025

11:15 T

Shareholders of Svetofor Group approved dividends

Yesterday at 18:36 SVET